Meet BrosMed at ASVS 2025
Release time:
2025-07-30
BrosMed Medical is delighted to participate in the ASVS 2025 Congress from August 29th to 31st in Singapore.
BrosMed Medical is delighted to participate in the ASVS 2025 Congress from August 29th to 31st in Singapore.
We can’t wait to engage with the masters and partners there, as well as showcase our comprehensive AVF&PAD solutions, including:
- Tri-Wedge™ PTA Scoring Balloon Catheter
Features three triangular metallic scoring elements for controlled, precise, and effective dilatation—ideal for treating AV fistula stenosis
- Comprehensive Workhorse PTA Balloon Catheters
Full range of OTW PTA NC balloons available in 0.014”, 0.018”, and 0.035” systems—designed to meet routine clinical demands with reliability and precision
- Tiche™ High-Pressure PTA Balloon Catheter
0.035” system delivering high-pressure performance up to 24 atm, combined with a low tip entry profile of 0.040” for excellent deliverability.
- Next-Generation Semi-Compliant PTA Balloon
Balloon lengths up to 300 mm and shaft lengths up to 200 cm to accommodate a wide range of peripheral procedures
- Vasecure™ Paclitaxel-Coated PTA Balloon Catheter
Innovative protective sheath ensures zero drug loss, while a proprietary drug-coating technique enhances immediate drug delivery for optimal therapeutic outcomes.
Let’s meet at BrosMed Medical Booth #B10. If you will participate in this fantastic event, please contact us via email: sales@brosmed.com. Looking forward to seeing you there!
ABOUT BROSMED MEDICAL
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production, and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers (Labs), and 2 manufacturing centers around China, Europe, and Asia Pacific. BrosMed has more than 20 product series and 600+ product registration certificates worldwide.
Previous Article
Next Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
